Sanjay Mistry

Sanjay Mistry is the director at Rapport Therapeutics. Joined Quaker Partners in 2008. Dr. Mistry focused on selecting investments across the biopharma and diagnostics/tools sectors. Prior to joining Quaker, he was an Assistant Director at Johnson & Johnson, where he held responsibilities in therapeutic area strategy planning and in the implementation and management of life science alliances for the Stem Cell Internal Ventures (SCIV) group. Prior to his business development roles, he led stem cell translational development in the area of retinal degeneration within the SCIV. Dr. Mistry also worked at Morphogen Pharmaceuticals and completed postdoctoral fellowships at the Scripps Research Institute and at the University of Pittsburgh Medical School. He holds a Ph.D. in Biochemical Pharmacology and an M.S. in Clinical Pharmacology from the University of Aberdeen and a B.Sc. in Applied Biology from Nottingham.